Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Jan 24, 2025 / 12:30 PM GMT

Release Date Price: ₹3248.4 (-0.47%)

Transcript

Key Points

Positve

Torrent Pharmaceuticals Ltd (BOM:500420) reported a strong performance in its branded market, accounting for 76% of overall revenues.
The India business showed a growth of 12% for the quarter, outperforming the market growth of 8%.
The chronic business, particularly in cardiac, diabetes, and gastro divisions, demonstrated robust growth, with cardiac growing by 16% against a market growth of 10%.
The company has expanded its coverage to 75,000 outlets, enhancing its market reach.
An interim dividend of INR26 per equity share was recommended, reflecting confidence in financial stability.

Negative

Insulin revenues were nil for the quarter due to facility release delays, impacting revenue growth by 2%.
The US business faced a decline in constant currency revenues by 3%, indicating challenges in that market.
Currency depreciation in Brazil affected financial performance, although the company expects price compensation from the government.
The CNS market in India showed slower growth compared to other segments, requiring more strategic focus.
The company anticipates continued impact from currency depreciation in Brazil for a couple more quarters.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TORP.NS - Torrent Pharmaceuticals Ltd
Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call
Jan 24, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day. And welcome to Q3 FY25 earnings conference call of torrent Pharma.

As a reminder, all participant lines will be in the listen-only more and there will be an option for you to ask questions after the presentation concludes.

Should you need assistance during the conference call? Please signal an operator by pressing star and zero on it thatone phone. Please note that this conference is being recorded.

I now hand the conference over to Mr Su Menin, Chief Financial Officer and Executive Director Finance. Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.